Srx Health Solutions Inc (SRXH) — Institutional Holders Breakdown (Q2 2026)

SRXH ranks #7469 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

SRXH is a disclosed holding of Ken Griffin (Citadel Advisors LLC), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

30 institutions disclose a position in SRXH, but none treat it as a major bet — even BlackRock, Inc., its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Geode Capital Management, LLC has added to its SRXH position for two straight quarters, increasing it by $608.2K to reach $634.4K today.

Sanctuary Advisors, LLC has trimmed its SRXH position for two straight quarters, cutting it by $2.1K while still holding $1.3K.

SRXH is down 4.8% today, but institutions show net buying of $4.2M this quarter — a divergence between today's price move and the underlying institutional flow.

SRXH reported a net loss of $34.4M over the trailing twelve months.

• Not yet profitable — net loss of $34.4M over the trailing twelve months
• Revenue declined 187.8% year over year
• Net income improved year over year, from -$61.2M to -$34.4M
• Operating cash flow was negative, using $8.1M in cash
• Current ratio of 2.29x — enough short-term assets to cover short-term liabilities
• Liabilities run 257.90x equity — a highly leveraged balance sheet worth noting